Skip to content

The PRP Uterine Boost: A New Approach to Help Women with Thin Endometrium Achieve Pregnancy

Effect of Intrauterine Perfusion with Different Concentrations of Platelet-Rich Plasma on Pregnancy Outcomes in Patients with Thin Endometrium Undergoing Frozen-Thawed Embryo Transfer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126585
Enrollment
Unknown
Registered
2026-06-11
Start date
2026-06-30
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility ? Thin Endometrium

Interventions

Control Group:none
Low-Concentration Group:Intrauterine infusion of platelet-rich plasma (low concentration)
Medium-Concentration Group:Intrauterine Perfusion with Platelet-Rich Plasma (medium concentration)
High-Concentration Group:Intrauterine Perfusion with Platelet-Rich Plasma(high concentration)

Sponsors

The Second Nanning People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 40 Years

Inclusion criteria

Inclusion criteria: 1.Age <= 40 years. 2.Previous cancellation of embryo transfer due to an endometrial thickness of < 7 mm on the day of human chorionic gonadotropin (hCG) administration in a natural or ovulation induction cycle, or on the day of endometrial transformation in a hormone replacement cycle. 3.Normal uterine cavity confirmed by hysteroscopy. If intrauterine adhesions were present, they must have been completely lysed during the procedure, with no signs of recurrence on postoperative three-dimensional ultrasonography. 4.Normal thyroid function, blood glucose, and blood lipid profiles. 5.Infertility attributable mainly to pelvic/tubal factors, ovulatory dysfunction, or male factors, with no significant concurrent medical or surgical diseases.

Exclusion criteria

Exclusion criteria: 1.History of estrogen-related malignancies; 2.Abnormal uterine cavity on hysteroscopy (e.g., untreated submucosal uterine fibroids); 3.Endometrial pathologies, including but not limited to endometrial hyperplasia, endometrial tuberculosis, or untreated endometritis. 4.Adenomyosis; 5.Endometriosis of American Society for Reproductive Medicine (ASRM) stages III-IV. 6.Severe bilateral hydrosalpinx; 7.History of recurrent implantation failure; 8.Unavailability of cryopreserved blastocysts for transfer;

Design outcomes

Primary

MeasureTime frame
Endometrial Thickness;Clinical Pregnancy Rate;

Countries

China

Contacts

Public ContactHaitao Yang

The Second Nanning People’s Hospital

77292261@qq.com+86 771 480 8339

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026